Journal of Thoracic Oncology, 15(3), 404-415. ELSEVIER SCIENCE INC Journal of Thoracic Oncology, 15(3), 404-415. International Association for the Study of Lung Cancer Huber, R M, Hansen, K H, Paz-Ares Rodríguez, L, West, H L, Reckamp, K L, Leighl, N B, Tiseo, M, Smit, E F, Kim, D-W, Gettinger, S N, Hochmair, M J, Kim, S-W, Langer, C J, Ahn, M-J, Kim, E S, Kerstein, D, Groen, H J M & Camidge, D R 2020, ' Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial ', Journal of Thoracic Oncology, vol. 15, no. 3, pp. 404-415 . https://doi.org/10.1016/j.jtho.2019.11.004 Huber, R M, Hansen, K H, Paz-Ares Rodríguez, L, West, H L, Reckamp, K L, Leighl, N B, Tiseo, M, Smit, E F, Kim, D W, Gettinger, S N, Hochmair, M J, Kim, S W, Langer, C J, Ahn, M J, Kim, E S, Kerstein, D, Groen, H J M & Camidge, D R 2020, ' Brigatinib in Crizotinib-Refractory ALK+ NSCLC : 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial ', Journal of Thoracic Oncology, vol. 15, no. 3, pp. 404-415 . https://doi.org/10.1016/j.jtho.2019.11.004
Kim, D W, Tiseo, M, Ahn, M J, Reckamp, K L, Hansen, K H, Kim, S W, Huber, R M, West, H L, Groen, H J M, Hochmair, M J, Leighl, N B, Gettinger, S N, Langer, C J, Rodríguez, L G P A, Smit, E F, Kim, E S, Reichmann, W, Haluska, F G, Kerstein, D & Camidge, D R 2017, ' Brigatinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small-cell lung cancer : A randomized, multicenter phase II trial ', Journal of Clinical Oncology, vol. 35, no. 22, pp. 2490-2498 . https://doi.org/10.1200/JCO.2016.71.5904 Journal of Clinical Oncology, 35(22), 2490-2498. AMER SOC CLINICAL ONCOLOGY Kim, D-W, Tiseo, M, Ahn, M-J, Reckamp, K L, Hansen, K H, Kim, S-W, Huber, R M, West, H L, Groen, H J M, Hochmair, M J, Leighl, N B, Gettinger, S N, Langer, C J, Paz-Ares Rodríguez, L G, Smit, E F, Kim, E S, Reichmann, W, Haluska, F G, Kerstein, D & Camidge, D R 2017, ' Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer : A Randomized, Multicenter Phase II Trial ', Journal of Clinical Oncology, vol. 35, no. 22, pp. 2490-2498 . https://doi.org/10.1200/JCO.2016.71.5904 Journal of Clinical Oncology, 35(22), 2490-2498. American Society of Clinical Oncology